Alpha 2.0
Login Register
» Articles » PMID: 34870933

SARS-CoV-2 Incidence, Testing Rates, and Severe COVID-19 Outcomes Among People with and Without HIV

Overview
Journal AIDS
Specialty Infectious Diseases
Date 2021 Dec 6
PMID 34870933
Citations 12
Authors
Matthew A Spinelli
Lillian B Brown
David V Glidden
Kyle Hunter
Patrick Martin-Tuite
James Zheng
Curtis Sera
Diane Havlir
Susan P Buchbinder
Monica Gandhi
Affiliations
Soon will be listed here.
Abstract

To assess SARS-CoV-2 outcomes, we matched a municipal COVID-19 registry and clinic rosters from a municipal primary care network containing a large HIV clinic and assessed clinical outcomes by HIV status. The risk of severe COVID-19 was higher among people with HIV (PWH, adjusted relative risk = 1.84, 95% confidence interval = 1.05-3.25), while SARS-CoV-2 incidence was lower despite higher testing rates. SARS-CoV-2 vaccination campaigns should prioritize PWH to prevent severe COVID-19 disease given potentially higher risk.

Citing Articles

Prevalence and Correlates of SARS-CoV-2 Vaccine Uptake and Hesitancy Among People With HIV Across the United States.

Spinelli M, Johnson M, Lisha N, Jain J, Moreira C, Glidden D J Acquir Immune Defic Syndr. 2024; 97(1):13-18.

PMID: 39116328 PMC: 11315354. DOI: 10.1097/QAI.0000000000003466.

Factors associated with SARS-CoV-2 infection among people living with HIV: Data from the Balearic cohort (EVHIA).

Artigues Serra F, Pinecki Socias S, Fanjul F, Penaranda M, Homar F, Sorni P PLoS One. 2024; 19(8):e0308568.

PMID: 39110761 PMC: 11305541. DOI: 10.1371/journal.pone.0308568.

SARS-CoV-2 Infection, Hospitalization, and Associated Factors Among People Living With HIV in Southeastern China From December 2022 to February 2023: Cross-Sectional Survey.

Cheng W, Xu Y, Jiang H, Li J, Hou Z, Meng H JMIR Public Health Surveill. 2024; 10:e51449.

PMID: 38630534 PMC: 11025603. DOI: 10.2196/51449.

Mortality Among Persons With HIV in the United States During the COVID-19 Pandemic: A Population-Level Analysis.

Viguerie A, Song R, Bosh K, Lyles C, Farnham P J Acquir Immune Defic Syndr. 2023; 95(2):126-132.

PMID: 37988697 PMC: 11278038. DOI: 10.1097/QAI.0000000000003347.

Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination.

Motsoeneng B, Manamela N, Kaldine H, Kgagudi P, Hermanus T, Ayres F Front Immunol. 2023; 14:1231276.

PMID: 37600825 PMC: 10435738. DOI: 10.3389/fimmu.2023.1231276.

References
1.
Spinelli M . SARS-CoV-2 vaccination in people with HIV. Lancet HIV. 2021; 8(8):e455-e456. PMC: 8213375. DOI: 10.1016/S2352-3018(21)00128-4. View
2.
Brown L, Spinelli M, Gandhi M . The interplay between HIV and COVID-19: summary of the data and responses to date. Curr Opin HIV AIDS. 2020; 16(1):63-73. PMC: 7735216. DOI: 10.1097/COH.0000000000000659. View
3.
Tesoriero J, Swain C, Pierce J, Zamboni L, Wu M, Holtgrave D . COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State. JAMA Netw Open. 2021; 4(2):e2037069. PMC: 7859843. DOI: 10.1001/jamanetworkopen.2020.37069. View
4.
Borgan O, Langholz B, Samuelsen S, Goldstein L, Pogoda J . Exposure stratified case-cohort designs. Lifetime Data Anal. 2000; 6(1):39-58. DOI: 10.1023/a:1009661900674. View
5.
Bhaskaran K, Rentsch C, Mackenna B, Schultze A, Mehrkar A, Bates C . HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV. 2020; 8(1):e24-e32. PMC: 7773630. DOI: 10.1016/S2352-3018(20)30305-2. View